TREATMENT OF THALASSEMIA MAJOR BY AYURVEDA

Further Clinical Study on Beejadushtijanya Pandu (Thalassemia Major) and Its Management with Gandhakadi Yoga - MANEGEMENT

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/03/006750

Enrollment

Registered

2016-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed cases of Thalassemia major

Interventions

Intervention1: Trial Group A Gandhakadi yog (agatsya patra bhavit) along with modern medical management : Diagnosed cases of thalassemia major DURATION OF THE TREATMENT 12 weeks FOLLOW UP 12 weeks d

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Thalassemia major

Exclusion criteria

Exclusion criteria: Children below 2 years and above 12 years of age. Cases having HIV, HBV infection, hepatic failure, DM, TB etc. Patient having BT interval for less than 12 days. Patient undergone Splenectomy.

Design outcomes

Primary

Measure	Time frame
Establish an adjuvant thera from ayurveda in order to 1 Prolonging the BT interval 2 Decrease the serum ferritin level 3 Enhance the life span of the thalassemic children 4 Increase the QOL of thalassemic patients 5 Minimise complication such as iron overloading pain etc Timepoint: Establish an adjuvant thera from ayurveda in order to 1 Prolonging the BT interval 2 Decrease the serum ferritin level 3 Enhance the life span of the thalassemic children 4 Increase the QOL of thalassemic patients 5 Minimise complication such as iron overloading pain etc	—

Measure

Time frame

Establish an adjuvant thera from ayurveda in order to 1 Prolonging the BT interval 2 Decrease the serum ferritin level 3 Enhance the life span of the thalassemic children 4 Increase the QOL of thalassemic patients 5 Minimise complication such as iron overloading pain etc Timepoint: Establish an adjuvant thera from ayurveda in order to 1 Prolonging the BT interval 2 Decrease the serum ferritin level 3 Enhance the life span of the thalassemic children 4 Increase the QOL of thalassemic patients 5 Minimise complication such as iron overloading pain etc

—

Secondary

Measure	Time frame
Enhance the life span of the thalassemic children Increase the QOL of thalassemic patients Timepoint: Prolonging the BT interval 2 Decrease the serum ferritin level	—

Countries

India

Contacts

Public ContactDr VKKori

IPGT and RA

drkspatel2007@yahoo.co.in9427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026